These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38842801)

  • 1. Cardiovascular Events and Androgen Receptor Signaling Inhibitors in Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
    El-Taji O; Taktak S; Jones C; Brown M; Clarke N; Sachdeva A
    JAMA Oncol; 2024 Jul; 10(7):874-884. PubMed ID: 38842801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Fractures and Falls in Men with Advanced or Metastatic Prostate Cancer Receiving Androgen Deprivation Therapy and Treated with Novel Androgen Receptor Signalling Inhibitors: A Systematic Review and Meta-analysis of Randomised Controlled Trials.
    Jones C; Gray S; Brown M; Brown J; McCloskey E; Rai BP; Clarke N; Sachdeva A
    Eur Urol Oncol; 2024 Oct; 7(5):993-1004. PubMed ID: 38383277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse Events and Androgen Receptor Signaling Inhibitors in the Treatment of Prostate Cancer: A Systematic Review and Multivariate Network Meta-analysis.
    Cao B; Kim M; Reizine NM; Moreira DM
    Eur Urol Oncol; 2023 Jun; 6(3):237-250. PubMed ID: 36682938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular and Thromboembolic Events in Patients With Localized Prostate Cancer Receiving Intensified Neoadjuvant Androgen Deprivation: A Systematic Review and Meta-Analysis.
    Felício de Campos E; Xavier CB; Queiroz MM; Firmino Lima Júnior N; Ilario EN; Coelho RF; Nahas WC; Bastos DA; Fontes Jardim DL
    Clin Genitourin Cancer; 2024 Jun; 22(3):102088. PubMed ID: 38718699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer.
    Sathianathen NJ; Oestreich MC; Brown SJ; Gupta S; Konety BR; Dahm P; Kunath F
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013245. PubMed ID: 33314020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of cardiovascular toxicities and hypertension in nonmetastatic castration-resistant prostate cancer patients treated with novel hormonal agents: a systematic review and meta-analysis.
    Rizzo A; Merler S; Sorgentoni G; Oderda M; Mollica V; Gadaleta-Caldarola G; Santoni M; Massari F
    Expert Opin Drug Metab Toxicol; 2021 Oct; 17(10):1237-1243. PubMed ID: 34407702
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis.
    Myint ZW; Momo HD; Otto DE; Yan D; Wang P; Kolesar JM
    JAMA Netw Open; 2020 Nov; 3(11):e2025826. PubMed ID: 33201234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen Receptor Signaling Inhibitors in Addition to Docetaxel with Androgen Deprivation Therapy for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review and Meta-analysis.
    Yanagisawa T; Rajwa P; Thibault C; Gandaglia G; Mori K; Kawada T; Fukuokaya W; Shim SR; Mostafaei H; Motlagh RS; Quhal F; Laukhtina E; Pallauf M; Pradere B; Kimura T; Egawa S; Shariat SF
    Eur Urol; 2022 Dec; 82(6):584-598. PubMed ID: 35995644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review.
    Devos G; Vansevenant B; De Meerleer G; Clinckaert A; Devlies W; Claessens F; Graefen M; Steuber T; Briganti A; de la Taille A; Van Poppel H; Joniau S
    World J Urol; 2021 Sep; 39(9):3177-3185. PubMed ID: 33580296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-steroidal antiandrogen monotherapy compared with luteinising hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer.
    Kunath F; Grobe HR; Rücker G; Motschall E; Antes G; Dahm P; Wullich B; Meerpohl JJ
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009266. PubMed ID: 24979481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular Toxicity Associated With Androgen Receptor Axis-Targeted Agents in Patients With Prostate Cancer: A Meta-analysis of Randomized Controlled Trials.
    Zhou S; Alerasool P; Kishi N; Joshi H; Sahni G; Tsao CK
    Clin Genitourin Cancer; 2024 Jun; 22(3):102066. PubMed ID: 38584004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular events among men with prostate cancer treated with androgen receptor signaling inhibitors: a systematic review, meta-analysis, and network meta-analysis.
    Matsukawa A; Yanagisawa T; Parizi MK; Laukhtina E; Klemm J; Fazekas T; Mori K; Kimura S; Briganti A; Ploussard G; Karakiewicz PI; Miki J; Kimura T; Rajwa P; Shariat SF
    Prostate Cancer Prostatic Dis; 2024 Sep; ():. PubMed ID: 39237679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Systemic Treatments for Metastatic Castration-Sensitive Prostate Cancer: A Systematic Review and Network Meta-analysis.
    Wang L; Paller CJ; Hong H; De Felice A; Alexander GC; Brawley O
    JAMA Oncol; 2021 Mar; 7(3):412-420. PubMed ID: 33443584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is androgen deprivation therapy for prostate cancer associated with cardiovascular disease? A meta-analysis and systematic review.
    Liang Z; Zhu J; Chen L; Xu Y; Yang Y; Hu R; Zhang W; Song Y; Lu Y; Ou N; Liu X
    Andrology; 2020 May; 8(3):559-574. PubMed ID: 31743594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Second-generation Antiandrogens With Cognitive and Functional Toxic Effects in Randomized Clinical Trials: A Systematic Review and Meta-analysis.
    Nowakowska MK; Ortega RM; Wehner MR; Nead KT
    JAMA Oncol; 2023 Jul; 9(7):930-937. PubMed ID: 37227736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
    Attard G; Murphy L; Clarke NW; Cross W; Jones RJ; Parker CC; Gillessen S; Cook A; Brawley C; Amos CL; Atako N; Pugh C; Buckner M; Chowdhury S; Malik Z; Russell JM; Gilson C; Rush H; Bowen J; Lydon A; Pedley I; O'Sullivan JM; Birtle A; Gale J; Srihari N; Thomas C; Tanguay J; Wagstaff J; Das P; Gray E; Alzoueb M; Parikh O; Robinson A; Syndikus I; Wylie J; Zarkar A; Thalmann G; de Bono JS; Dearnaley DP; Mason MD; Gilbert D; Langley RE; Millman R; Matheson D; Sydes MR; Brown LC; Parmar MKB; James ND;
    Lancet; 2022 Jan; 399(10323):447-460. PubMed ID: 34953525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cardiovascular Toxicity of Abiraterone and Enzalutamide in Prostate Cancer.
    Iacovelli R; Ciccarese C; Bria E; Romano M; Fantinel E; Bimbatti D; Muraglia A; Porcaro AB; Siracusano S; Brunelli M; Mazzarotto R; Artibani W; Tortora G
    Clin Genitourin Cancer; 2018 Jun; 16(3):e645-e653. PubMed ID: 29339044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonates or RANK-ligand-inhibitors for men with prostate cancer and bone metastases: a network meta-analysis.
    Jakob T; Tesfamariam YM; Macherey S; Kuhr K; Adams A; Monsef I; Heidenreich A; Skoetz N
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013020. PubMed ID: 33270906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.